Clorox Cleans Up and Then Some in Q1
Clorox reported better than expected first-quarter financial results before the opening bell on Monday.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
When Clorox Co. (NYSE: CLX | CLX Price Prediction) reported its first-quarter financial results before the opening bell on Monday, the firm said that it had $3.22 in earnings per share (EPS) and $1.92 billion in revenue, while consensus estimates that called for $2.32 in EPS on $1.75 billion in revenue. The same period of last year reportedly had $1.59 in EPS and $1.51 billion in revenue.
During the most recent quarter, sales increased 27% year over year, driven by double-digit growth in eight of 10 business units due to COVID-19 and people spending more time at home. Also, EPS results reflect higher sales and gross margin expansion.
In terms of its segments, the company reported:
- Health and Wellness revenues increased 28% year over year to $813 million.
- Household revenue increased by 39% to $500 million.
- Lifestyle revenue grew 17% to $318 million.
- International revenue increased by 18% to $285 million.
Net cash provided by operations was $383 million, compared to $271 million in the year-ago period. On the books, Clorox cash and cash equivalents totaled $860 million, up from $150 million at the end of the same period last year.
[nativounit]
Looking ahead to the 2021 fiscal full year, Clorox expects to see EPS in the range of $7.70 to $7.95 and sales growth of 5% to 9%. Consensus estimates are calling for $7.69 in EPS and $6.93 billion in revenue for the year.
Clorox stock traded up 5% at $218.23 on Monday, in a 52-week range of $144.31 to $239.87. The consensus price target is $223.23.
[recirclink id=804096][wallst_email_signup]
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
